Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson(Peter MacCallum Cancer Centre), Ian Campbell(The University of Sydney), Rodney J. Scott(New South Wales Department of Health), Alison H. Trainer(The Royal Melbourne Hospital), Simone McInerny(Peter MacCallum Cancer Centre), Simone M. Rowley(Victorian Clinical Genetics Services), Michelle W. Wong‐Brown(Peter MacCallum Cancer Centre), Na Li(Peter MacCallum Cancer Centre), Lisa Devereux(Peter MacCallum Cancer Centre), Gillian Mitchell(Peter MacCallum Cancer Centre), Paul A. James(The Royal Melbourne Hospital)
Cited by 184
Related Papers
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939